Based on the Aster DM Healthcare Limited stock forecast from 1 analysts, the average analyst target price for Aster DM Healthcare Limited is INR 620.00 over the next 12 months. Aster DM Healthcare Limited’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Aster DM Healthcare Limited is Slightly Bearish, which is based on 5 positive signals and 9 negative signals. At the last closing, Aster DM Healthcare Limited’s stock price was INR 499.50. Aster DM Healthcare Limited’s stock price has changed by -0.16% over the past week, +16.31% over the past month and -4.05% over the last year.
No recent analyst target price found for Aster DM Healthcare Limited
No recent average analyst rating found for Aster DM Healthcare Limited
Company Overview Aster DM Healthcare Limited
Aster DM Healthcare Limited, together with its subsidiaries, provides healthcare and allied services in India, the United Arab Emirates, Qatar, Oman, Kingdom of Saudi Arabia, Jordan, Kuwait and Bahrain, and Republic of Mauritius. It operates through Hospitals, Clinics, Retail Pharmacies, and Others segments. The company operates hospitals and in-house pharmacies at the hospitals; and clinics and in-house pharmacies at the clinics, as well as retail and online pharmacies and optical outlets. It also offers healthcare consultancy and other services. Aster DM Healthcare Limited was founded in 1987 and is headquartered in Dubai, United Arab Emirates. Read Less
Aster DM Healthcare Limited, together with its subsidiaries, provides healthcare and allied services in India, the United Arab Emirates, Qatar, Oman, Kingdom of Saudi Arabia, Jordan, Kuwait and Bahrain, and Republic of Mauritius. It operates through Hospitals, Clinics, Retail Pha...Read More
Frequently Asked Questions About Aster DM Healthcare Limited (ASTERDM:NSE) Stock
Based on ratings from 1 analysts Aster DM Healthcare Limited's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and hold ratings.
ASTERDM:NSE stock's dividend yield is 1.65%.
Our analysis grades ASTERDM:NSE stock's dividend yield at A+. This means that ASTERDM:NSE stock's dividend yield is above 100% of the stocks in the Medical Care Facilities sector in the NSE exchange.
Based on this ASTERDM:NSE may be a good dividend stock for its sector.
Based on targets from 1 analysts, the average taret price for ASTERDM:NSE is INR 620.00 over the next 12 months. The maximum analyst target price is INR 620 while the minimum anlayst target price is INR 620.
ASTERDM:NSE stock's Price/Earning ratio is 119.09.
Our analysis grades ASTERDM:NSE stock's Price / Earning ratio at F. This means that ASTERDM:NSE stock's Price/Earning ratio is above 79% of the stocks in the Medical Care Facilities sector in the NSE exchange.
Based on this ASTERDM:NSE may be a overvalued for its sector.
The last closing price of ASTERDM:NSE's stock was INR 499.50.
The most recent market capitalization for ASTERDM:NSE is INR 241.49B.
Based on targets from 1 analysts, the average taret price for ASTERDM:NSE is projected at INR 620.00 over the next 12 months.
This means that ASTERDM:NSE's stock price may go up by +24.12% over the next 12 months.
We can't find any ETFs which contains Aster DM Healthcare Limited's stock.
As per our most recent records Aster DM Healthcare Limited has 14,016 Employees.
Aster DM Healthcare Limited's registered address is Tower D - Aspect Tower, Dubai, United Arab Emirates.
You can get more information about it from Aster DM Healthcare Limited's website at https://www.asterdmhealthcare.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Aster DM Healthcare Limited (ASTERDM:NSE) Stock
Based on ratings from 1 analysts Aster DM Healthcare Limited's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and hold ratings.
ASTERDM:NSE stock's dividend yield is 1.65%.
Our analysis grades ASTERDM:NSE stock's dividend yield at A+. This means that ASTERDM:NSE stock's dividend yield is above 100% of the stocks in the Medical Care Facilities sector in the NSE exchange.
Based on this ASTERDM:NSE may be a good dividend stock for its sector.
Based on targets from 1 analysts, the average taret price for ASTERDM:NSE is INR 620.00 over the next 12 months. The maximum analyst target price is INR 620 while the minimum anlayst target price is INR 620.
ASTERDM:NSE stock's Price/Earning ratio is 119.09.
Our analysis grades ASTERDM:NSE stock's Price / Earning ratio at F. This means that ASTERDM:NSE stock's Price/Earning ratio is above 79% of the stocks in the Medical Care Facilities sector in the NSE exchange.
Based on this ASTERDM:NSE may be a overvalued for its sector.
The last closing price of ASTERDM:NSE's stock was INR 499.50.
The most recent market capitalization for ASTERDM:NSE is INR 241.49B.
Based on targets from 1 analysts, the average taret price for ASTERDM:NSE is projected at INR 620.00 over the next 12 months.
This means that ASTERDM:NSE's stock price may go up by +24.12% over the next 12 months.
We can't find any ETFs which contains Aster DM Healthcare Limited's stock.
As per our most recent records Aster DM Healthcare Limited has 14,016 Employees.
Aster DM Healthcare Limited's registered address is Tower D - Aspect Tower, Dubai, United Arab Emirates.
You can get more information about it from Aster DM Healthcare Limited's website at https://www.asterdmhealthcare.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ASTERDM:NSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
